VanEck Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Hold |
4,172
| – | – | ﹤0.01% | 1352 |
|
|
2025
Q1 | $34K | Hold |
4,172
| – | – | ﹤0.01% | 1316 |
|
|
2024
Q4 | $39K | Buy |
4,172
+715
| +21% | +$6.68K | ﹤0.01% | 1306 |
|
|
2024
Q3 | $39K | Sell |
3,457
-1,107
| -24% | -$12.5K | ﹤0.01% | 1283 |
|
|
2024
Q2 | $45K | Hold |
4,564
| – | – | ﹤0.01% | 1294 |
|
|
2024
Q1 | $54K | Sell |
4,564
-93
| -2% | -$1.1K | ﹤0.01% | 1279 |
|
|
2023
Q4 | $66K | Buy |
4,657
+873
| +23% | +$12.4K | ﹤0.01% | 1268 |
|
|
2023
Q3 | $46K | Buy |
3,784
+161
| +4% | +$1.96K | ﹤0.01% | 1289 |
|
|
2023
Q2 | $46K | Buy |
3,623
+312
| +9% | +$3.96K | ﹤0.01% | 1304 |
|
|
2023
Q1 | $37K | Buy |
3,311
+323
| +11% | +$3.61K | ﹤0.01% | 1324 |
|
|
2022
Q4 | $36K | Buy |
2,988
+981
| +49% | +$11.8K | ﹤0.01% | 1331 |
|
|
2022
Q3 | $21K | Buy |
+2,007
| New | +$21K | ﹤0.01% | 1316 |
|